Management of Hypertension in Adults with Cardiovascular Disease

Immediate Treatment Initiation

The European Society of Cardiology recommends starting pharmacological treatment promptly for any patient with confirmed blood pressure ≥140/90 mmHg who has established cardiovascular disease, regardless of additional risk stratification 1, 2
The presence of cardiovascular disease automatically places this patient in the high-risk category, eliminating the need for 10-year ASCVD risk calculation, according to the American College of Physicians 3, 4
The European Society of Cardiology advises against delaying treatment with lifestyle modifications alone—both lifestyle measures and pharmacological therapy must be initiated simultaneously 1, 2

The European Society of Cardiology recommends a preferred combination of ACE inhibitor or ARB plus dihydropyridine calcium channel blocker as initial treatment 1, 2, 5
The American Heart Association suggests using a fixed-dose single-pill combination whenever possible to improve adherence 1, 2, 5

The European Society of Cardiology recommends targeting a systolic blood pressure of 120-129 mmHg for most adults with cardiovascular disease, provided treatment is well tolerated 1, 2, 5
The American College of Physicians notes that this lower target is based on evidence showing continuing reduction in cardiovascular events at progressively lower systolic blood pressure levels 3, 4

The European Society of Cardiology advises escalating to a three-drug combination, including a RAS blocker, dihydropyridine CCB, and thiazide/thiazide-like diuretic, if blood pressure is not controlled with the initial two-drug combination 1, 2, 5
The American College of Physicians recommends reassessing blood pressure within 2-4 weeks after initiating or adjusting therapy 3, 4, 7

The European Society of Cardiology recommends implementing lifestyle modifications, including smoking cessation, weight management, dietary modifications, sodium restriction, and physical activity, concurrently with pharmacological therapy 1, 2, 5
The American Heart Association suggests limiting sodium intake to <2 g/day and increasing potassium intake through potassium-enriched salt or fruits and vegetables 1, 8

The European Society of Cardiology advises reassessing blood pressure, adherence, and tolerance within 2-4 weeks of starting or adjusting therapy, and following up at least yearly for blood pressure and other cardiovascular risk factors once controlled 1, 3, 4, 7
The American College of Physicians recommends maintaining blood pressure-lowering medication indefinitely, even beyond age 85 years, if well tolerated 1, 2, 5, 7

The European Society of Cardiology warns against combining two RAS blockers, as this increases adverse effects without additional benefit 2, 5, 7
The American Heart Association advises against using monotherapy in patients with confirmed hypertension ≥140/90 mmHg, as combination therapy is more effective 1, 2, 5